ARCT vs MSFT: Which Stock is Better?
Side-by-side comparison of Arcturus Therapeutics Holdings Inc and Microsoft Corp in 2026
ARCT
Arcturus Therapeutics Holdings Inc
$6.39
MSFT
Microsoft Corp
$395.22
Key Metrics Comparison
| Metric | ARCT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $181.62M | N/A | ARCT |
| P/E Ratio | N/A | 25.00 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | -0.7% | 0.2% | MSFT |
| Gross Margin | -36.8% | 68.6% | MSFT |
Analyze ARCT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARCT or MSFT a better investment?
Comparing ARCT and MSFT: Arcturus Therapeutics Holdings Inc has a market cap of $181.62M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARCT and MSFT?
ARCT (Arcturus Therapeutics Holdings Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARCT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARCT or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.7% for ARCT.
Which company is more profitable: ARCT or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -36.8% for ARCT.
Which is the larger company: ARCT or MSFT?
Arcturus Therapeutics Holdings Inc (ARCT) is larger with a market cap of $181.62M compared to N/A for MSFT.
Should I buy ARCT or MSFT in 2026?
Both ARCT and MSFT have investment merit. ARCT trades at $6.39 while MSFT trades at $395.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARCT and MSFT stock?
Key differences: Market Cap ($181.62M vs N/A), P/E Ratio (N/A vs 25.0x), Revenue Growth (-0.7% vs 0.2%), Gross Margin (-36.8% vs 68.6%).